Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Mol Ther. 2008 Aug 26;16(11):1783–1788. doi: 10.1038/mt.2008.185

Figure 5.

Figure 5

Photomicrographs of brain sections revealing antitumor efficacy of stereotactic CED of d106 in combination with ionizing radiation (10 Gy) in athymic nude mice implanted with human U87-MG xenografts. Magnification, 40X. a, Hematoxylin/eosin- (left) and GFP-stained (right) sections day 12 after tumor implantation (shown by *) and 7 days after d106 CED showing regression of xenograft (shown by arrow). b, GFP-stained section revealing complete tumor regression on day 17 after tumor implantation (shown by arrow). c, Hematoxylin/eosin-stained section day 17 after tumor implantation in animal that underwent intracerebral CED of HBSS and irradiation showing a large tumor (shown by *).